Restoring Nerve Function

Solaxa is a clinical-stage biopharmaceutical company developing treatments for
rare neurodegenerative disease and nerve injury.

We are pursuing both novel and reformulated drugs to
restore nerve function by targeting ion channels.

Our Company: By The Numbers

10

Different ataxias have shown a treatment response

280+

Ataxia patients studied

20

9 issued and 11 pending US, EU, Canada patents exclusively licensed

30+

Peer-reviewed publications by co-founders

$19M

Non-dilutive NIH & DoD grants to co-founders and clinical trial partners

Scroll to Top